ArticleDiscover oncology2024

IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.

Yuanhui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.